Adriamycine-Induced Cardiomyopathy

Marios Lemoniatis
2015 Journal of Medical Cases  
Adriamycin is an antineoplastic agent used in a wide variety of malignancies. Its use is limited because of a cumulative, dose-dependent irreversible cardiomyopathy. We report a case of adriamycin-induced cardiomyopathy, after he had undergone chemotherapy for Hodgin lymphoma. The patient had no cardiac risk factors, and neither laboratory nor imaging findings suggested myocarditis or dilated cardiomyopathy. Echocardiographic findings and differential diagnosis led us to attribute his condition
more » ... ibute his condition to subacute doxorubicin-induced cardiomyopathy.
doi:10.14740/jmc2132w fatcat:d22gekcmhbgxffk32ln4ighcte